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Rapid Androgen Actions on Calcium Signaling in Rat Sertoli Cells and Two Human
Prostatic Cell Lines: Similar Biphasic Responses Between 1 Picomolar and 100
Nanomolar Concentrations1
F.M. Lyng,3 G.R. Jones,3 and F.F.G. Rommerts2,4
Daresbury Laboratory,3 Daresbury, Warrington, Cheshire WA4 4AD, United Kingdom
Department of Endocrinology and Reproduction,4 Erasmus University, Rotterdam, The Netherlands
ABSTRACT
Androgen-induced calcium fluxes and gap junctional inter-
cellular communication (GJIC) were studied in three different
cell types. A transient (2–3 min duration) increase in intracel-
lular calcium levels was observed within 20–30 sec of androgen
addition, which was followed by a plateau phase with steroid
concentrations higher than 1 nM. The kinetics of the calcium
responses were similar in immature rat Sertoli cells, which con-
tain normal nuclear receptors; the human prostatic tumor cell
line, LNCaP, which contains a mutated nuclear receptor; and
the human prostatic cell line, PC3, which does not contain a
nuclear receptor. The human A431 tumor cell line did not re-
spond to androgens. Concentrations of testosterone and the syn-
thetic androgen, R1881, between 1–1000 pM induced transient
calcium increases with ED50 values near 1 pM and 1 nM, where-
as dihydrotestosterone (DHT) was not active at these concen-
trations. At concentrations higher than 1 nM, testosterone,
R1881, and DHT were equipotent in stimulating an increase in
calcium that lasted for more than 10 min, with ED50 values be-
tween 5 and 20 nM. Testosterone covalently bound to albumin
was also active, whereas 11 related androstane compounds as
well as progesterone and estradiol-17b were inactive at 1000
nM. The calcium response induced by the three androgens (10
nM) was abolished in all cell types by hydroxyflutamide (1000
nM) and finasteride (1000 nM), but not by cyproterone acetate
(1000 nM). The calcium response was also abolished in the ab-
sence of extracellular calcium and strongly inhibited by the pres-
ence of verapamil. Exposure of the responsive cells to brief (150-
sec) pulses of androgens generated calcium responses that were
similar to those after continuous exposure. After exposure of
Sertoli cells for only 30 sec to 100 nM testosterone, the calcium
response lasted for at least 50 min. Although nuclear binding of
androgens could be demonstrated, there was no evidence for
tight binding to the plasma membrane under similar conditions.
When protein synthesis was inhibited, an enhancement of GJIC
between rat Sertoli cells, but not between LNCaP cells or PC3
cells, was observed within 15 min of the addition of 10 nM
testosterone. Because nuclear androgens are not present in PC3
cells and many functional properties of the responsive system
are different from the nuclear receptor in all three cell types,
we postulate the existence of an alternative cell surface receptor
system with biphasic response characteristics (high and low af-
finity). The calcium signals are probably coupled to the regula-
1This work was generously supported by the Ernst Schering Research
Foundation.
2Correspondence: F.F.G. Rommerts, Department of Endocrinology and Re-
production, Erasmus University Rotterdam, P.O. Box 1738, 3000 DR Rot-
terdam, The Netherlands. FAX: 31 104 089 461;
e-mail: rommerts@endov.fgg.eur.nl
Received: 7 June 1999.
First decision: 6 July 1999.
Accepted: 28 April 2000.
Q 2000 by the Society for the Study of Reproduction, Inc.
ISSN: 0006-3363. http://www.biolreprod.org
tion of gap junctional efficiency between Sertoli cells. The low-
affinity receptors may convey complementary androgen signals
at elevated local levels such as in the testis, when nuclear re-
ceptors are (over)saturated.
calcium, hormone action, prostate, Sertoli cells
INTRODUCTION
Spermatogenesis occurs when testicular levels of andro-
gens are much higher than peripheral androgen levels [1,
2]. Although the discussions about the minimal amount of
testosterone that is required for maintenance of spermato-
genesis are still ongoing, there is no doubt that concentra-
tions higher than the normal peripheral levels of testoster-
one are required [3, 4]. Because Sertoli cells are central to
the regulation of spermatogenesis, it is possible that specific
Sertoli cell functions can be sufficiently stimulated only by
these high concentrations of androgens. This hypothesis is
supported by the observation that androgen binding protein
(ABP) secretion in vitro by a combination of rat Sertoli
cells and peritubular myoid cells can be stimulated only by
free testosterone doses of between 4 and 20 nM [5], where-
as androgen-responsive cells derived from peripheral or-
gans, such as LNCaP cells and cell lines that have been
transfected with the androgen receptor, show a full response
to androgens between 0.1 and 1 nM [6].
The major mechanism of action of androgens is via high-
affinity receptors in the nucleus through activation of DNA
transcription. The saturation level of nuclear high-affinity
androgen receptors is close to 1 nM, which is in accordance
with many observed biological responses. It is difficult to
envisage how these high-affinity receptors can sense and
respond further to androgen levels above their saturation
point. An independent low-affinity transducing system, act-
ing in conjunction with the high-affinity receptors, may ex-
plain the odd response characteristics of testicular cells [7].
Supporting such an alternative receptor system is the ob-
servation that in vitro spermatogonial multiplication in eels
can be stimulated only with 11 keto-testosterone, for which
no nuclear receptor has been identified, whereas testoster-
one and dihydrotestosterone (DHT), for which nuclear re-
ceptors have been identified, were not active [8].
In recent years, a variety of membrane actions of steroids
have been reported for otherwise nuclear oriented ligands,
such as progesterone [9, 10], estrogens [11, 12], corticoste-
rone [13], aldosterone [14, 15], and vitamin D [16, 17].
This is also discussed in a general review by Wehling [18]
and, more specifically, for reproductive organs by Revelli
et al. [19]. Many of these steroids can induce transient el-
evations of intracellular calcium within 1 min, and many
authors have explained these phenomena by postulating the
existence of receptors for steroids in the plasma membrane
that differ from the nuclear receptors.
Androgens can also induce rapid calcium fluxes in a va-
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riety of cell types, including human prostatic cancer cells
(LNCaP; [20]), rat heart myocytes [21], male (but not fe-
male) rat osteoblasts [22], and mouse T cells, in which the
presence of a functional classical androgen receptor could
not be demonstrated [23, 24]. Recently, it was shown that
human granulosa cells show a calcium response to andro-
stenedione but not to testosterone [25]. Furthermore, Gor-
czynska and Handelsman [26] have shown rapid calcium
fluxes following addition of high concentrations of andro-
gens to freshly isolated immature rat Sertoli cells. However,
the doses of testosterone required for a response (between
300 and 3000 nM) were far in excess of the already high
local testicular levels (estimated free testosterone 20–60
nM [2]). This poor response of the freshly isolated cells
may have been influenced by membrane damage during the
enzymatic isolation procedure, as has been shown for glu-
cocorticoid receptors in the plasma membrane of lymphoma
cells [27].
In an effort to understand the mechanisms of action of
androgens, we have investigated various characteristics of
androgen-induced calcium signaling and as an immediate
functional expression of this regulatory pathway, gap junc-
tional intercellular communication (GJIC). Because there
are observations that estrogen receptors (perhaps modified)
can activate signaling pathways at the plasma membrane
[28, 29] and, because suggestions have been made that this
could hold also for androgen receptors [30], we have not
only investigated rat Sertoli cells, but also the human pros-
tate cancer cell line, LNCaP, which possesses a mutated
androgen receptor [6], and the androgen-insensitive human
prostate cancer line, PC3, in which mRNA for the androgen
receptor could not be detected [31].
MATERIALS AND METHODS
Primary Culture of Seminiferous Tubules
Testes from 21- to 25-day-old Wistar rats (Biological
Services Unit, University of Manchester, UK) were col-
lected in 10 ml Dulbeccos PBS containing 1 mM Ca21 and
1 mM Mg21. The tunica albuginea was removed and the
tissue was incubated in 1 mg/ml collagenase (type 1A, ac-
tivity .125 collagen digestion units per mg solid; Sigma
Chemical Company, St. Louis, MO) in PBS containing 1
mM Ca21 and 1 mM Mg21 at 378C for 30 min. Incubation
was terminated by addition of 10 ml culture medium con-
taining 1% fetal calf serum (FCS; Gibco, Paisley, Strath-
clyde, UK) and pieces of seminiferous tubules were col-
lected after sedimentation at gravity. One drop of a con-
centrated suspension of tubular fragments was added to a
glass coverslip in a culture dish with RPMI 1640 medium
without phenol red (Sigma) containing 1% FCS. Tubules
were cultured for 1–4 days at 378C in a humidified atmo-
sphere of 5% CO2. During this period the Sertoli cells mi-
grated away from the explants. Close to the remnants of
the tubular fragments, clusters of germ cells remained at-
tached to the flat monolayer of Sertoli cells and, at the
periphery, only a monolayer of Sertoli cells existed [32].
Culture of Cell Lines
LNCaP cells [33] and PC3 cells [34] were grown in
normal RPMI 1640 medium without phenol red (Sigma)
supplemented with 7.5% FCS. The human epidermal car-
cinoma cell line, A431 [35], was grown in normal DMEM
without phenol red (Sigma) supplemented with 10% FCS.
All cells were incubated for 2–3 days at 378C in a humid-
ified atmosphere of 5% CO2 before they were used for mea-
surements.
Chemicals
Testosterone (4-androsten-17b-ol-3-one), androstenedione
(4-androstene-3,17-dione), epitestosterone (4-androsten-17a-
ol-3-one), 5b-dihydrotestosterone (5b-androstane-17b-ol-3-
one), 5a-dihydrotestosterone (5a-androstane-17b-ol-3-one),
5a-androst-16-en-3a-ol, estradiol-17b (1,3,5(10)-estratriene-
3,17b-diol), progesterone (4-pregnene-3,20-dione), 11b-hy-
droxyandrostenedione (4-androsten-11b-ol-3,20-dione), dehy-
droepiandrosterone (5-androsten-3b-ol-17-one), 5b-androstan-
3b-ol-17–one, 5a-androstane-3,17-dione, 5a-androst-3-one,
5a-androst-16-en-3-one, and 5a-androst-16-en-3b-ol were all
obtained from Steraloids (Newport, RI). R1881 (17b-hy-
droxy-17a-methyl-estra-4,9,11-trien-3-one) was a gift from
Roussel UCLAF (Romainville, France). Cyproterone acetate
and hydroxyflutamide (HF) were gifts from Schering (Berlin,
Germany). Human recombinant hFSH (Org 32489) was a gift
from Organon (Oss, The Netherlands). Finasteride, testoster-
one 3-(O-carboxy methyl)oxime:BSA (29 mol steroid/mol
BSA), testosterone 3-(O-carboxy methyl) oxime BSA-fluores-
cein isothiocyanate conjugate (FITC), bovine albumin-fluo-
rescein isothiocyanate, epidermal growth factor (EGF), cyclo-
heximide, lucifer yellow CH, and the ionophore A23187 were
obtained from Sigma. All compounds were dissolved in eth-
anol. Fluo 3 and Fura Red acetoxymethyl (AM) ester (Mo-
lecular Probes, Leiden, The Netherlands) were dissolved in
DMSO. All dilutions were made in buffer solutions so that
the final concentration of ethanol or DMSO was less than
0.1%.
Loading With Fluo 3 and Fura Red AM Esters
Cultures were washed twice with a buffer containing 130
mM NaCl, 5 mM KCl, 1 mM Na2HPO4, 1 mM CaCl2, 1
mM MgCl2, and 25 mM Hepes (pH 7.4). Cells were loaded
with the calcium-sensitive dyes by incubation with 3 mM
Fluo 3 and 3 mM Fura Red AM esters for 1 h in the buffer
at 378C. Subsequently, the cultures were washed three times
with buffer and the glass coverslip carrying the cells was
mounted in a temperature-controlled microperfusion cham-
ber constructed of aluminum with a volume of 1 ml. It was
possible to rapidly change conditions with a perfusion rate
of 2 ml/min. At a constant perfusion, a steady state con-
centration of ligands could be maintained. This is especially
important when ligands can be metabolized by the cells. In
some experiments, cells were preincubated for 20 min with
inhibitors prior to calcium measurements.
Ratiometric Measurement of Calcium
The fluorescence intensity from a 100-mm2 area, corre-
sponding to approximately 10 fluorescently loaded cells,
was measured using a high-sensitivity low-irradiance mi-
crofluorimeter [36]. Fluo 3 and Fura Red [37–39] were ex-
cited at 488 nm using light from the Daresbury Laboratory
synchrotron radiation source, which provided long-term sta-
bility and low irradiance. Fluorescence emissions were si-
multaneously recorded at 525 nm and 660 nm. Fluores-
cence intensities were integrated every 2 sec for periods of
15 min with hormones being added 2 min after the start of
the measurement. The data were analyzed using in-house
data analysis software (http://www.dl.ac.uk/SRS/NCD/
manual.otoko.html) to generate the Fluo 3/Fura Red fluo-
rescence ratios. Because ratios could be calculated imme-
738 LYNG ET AL.
FIG. 1. Kinetics of calcium response after hormonal stimulation of Sertoli cells. Intracellular calcium levels in rat Sertoli cells before and during
perfusion with a) EGF (100 nM) or FSH (100 nM) and b) testosterone (0.1 pM–1000 nM). The black bar indicates the presence of hormone in the
perfusion medium. Ca21 was measured after loading cells with calcium-sensitive fluorescent dyes, Fluo 3 and Fura Red, as indicated in Materials and
Methods. Data are representative of at least six individual experiments. Similar curves for androgens were obtained when human LNCaP cells or PC3
cells were used.
diately, a group of cells that gave a constant ratio could be
easily positioned under the objective lens.
Correlation of the Fluo 3/Fura Red fluorescence ratios
to absolute calcium concentrations was performed using a
2-point in situ calibration method similar to that described
by Foskett et al. [40]. The minimum fluorescence ratio
(Rmin) for Fluo 3 and Fura Red in the absence of calcium
was determined from the fluorescence of Fluo 3/Fura Red-
loaded cells exposed to 5 mM ionophore A23187 in a zero
Ca21 buffer containing 10 mM EGTA. Normal intracellular
calcium levels were restored within 30 sec when cells ex-
posed to zero calcium were perfused again with normal
buffer containing 1 mM calcium in the absence of iono-
phore. This indicates that the effects of the ionophore under
these conditions are reversible. The maximum fluorescence
ratio (Rmax) was determined from the fluorescence of cells
exposed to 5 mM ionophore A23187 in a 10 mM Ca-EGTA
buffer with 600 nM free-Ca21.
Binding of Androgens
Binding of tritium-labeled R1881 was measured in intact
cells as described previously [41]. With this technique, spe-
cific, low-capacity binding to the nuclear receptor can be
discriminated from nonspecific high-capacity binding to
cellular proteins by comparing cellular binding in the ab-
sence and presence of an excess, unlabeled steroid.
Scrape Loading-Dye Transfer Technique
Cultures were washed in PBS and incubated in 0.05%
lucifer yellow CH in PBS. Scrape lines were made with a
needle in the cell monolayer and the cultures were left un-
disturbed for 3 min. The cultures were washed several times
with PBS and examined with a Zeiss epifluorescence mi-
croscope. The fluorescent dye enters the primary cells on
either side of the scrape line and is subsequently transferred
through gap junctions into adjoining cells. The extent of
dye transfer from the primary cells to the adjoining cells
gives a measure of GJIC [42]. The percentage of fluores-
cently labeled cells in a defined area was used as a quan-
titative measure of GJIC in control and treated cells.
Data Analysis
Measurements of Ca21 are presented as mean values 6
SEM of n independent experiments, each performed in trip-
licate. Significance of differences was determined by an
unpaired Student’s t-test and the differences were consid-
ered significant if P , 0.001.
RESULTS
Measurement of Calcium and Effects of Protein
Hormones
At the start of the experiment, the Fluo 3/Fura Red fluo-
rescence ratio values varied between 0.3 and 1.3. This
could indicate either cellular heterogeneity in calcium lev-
els or variations in dye loading. Therefore, various cell ar-
eas were prescreened to select a group of approximately 10
cells that gave the standard starting ratio value of 0.5,
which was the mean of the distribution.
In order to test the analytical system and the respon-
siveness of the cells, calcium responses were measured af-
ter exposure of the cells to protein hormones because it is
known that Sertoli cells respond to FSH and EGF [43],
whereas LNCaP [44] and A431 cells [35] respond only to
EGF. Figure 1a shows the typical rapid response pattern of
Sertoli cells to high concentrations of EGF and FSH: a
transient calcium peak followed by a plateau phase higher
than basal level, but lower than the peak level.
Kinetics and Dose-Response Properties of Androgens
Rapid increases in calcium levels were also found fol-
lowing addition of androgens. Typical responses for testos-
terone are shown in Figure 1b for rat Sertoli cells. Similar
responses were seen for LNCaP cells and PC3 cells. A431
cells did not respond to androgens and served as controls.
In all responding cells, different kinetics were observed,
depending on the dose of androgen used. In general, low
concentrations of androgens generated a transient peak last-
ing 2–3 min after a delay of approximately 20 sec. The
lowest dose of testosterone and R1881 to show a response
was 1 pM. Higher androgen concentrations caused an in-
crease in the peak height. At concentrations higher than 10
nM testosterone, R1881, or DHT for rat Sertoli cells and 1
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FIG. 2. Dose dependence of calcium responses. Dose-response curves for 0.1 pM–1000 nM testosterone (T), R1881 (R), and DHT (D) were constructed
from intracellular calcium levels 2 min after hormone addition (a–c) and 10 min after hormone addition (d–f) for rat Sertoli cells (a,d), human LNCaP
cells (b,e), and human PC3 cells (c,f). Mean values 6 SEM of three individual experiments performed in triplicate are given. * P , 0.005 compared
with controls.
TABLE 1. Approximate ED50 valuesa of testosterone, R1881, and dihydrotestosterone for half-maximal stimulation of high- and low-affinity receptive
systems in rat Sertoli cells, LNCaP cells, and PC3 cells.
Ligand
Transient high-affinityb
T DHT R1881
Transient low-affinityc
T DHT R1881
Steady-state low-affinityd
T DHT R1881
Sertoli cells
LNCaP cells
PC3 cells
0.5 pM
0.5 pM
5 pM
—
—
—
0.5 pM
0.5 pM
5 pM
2 nM
5 nM
5 nM
5 nM
5 nM
5 nM
2 nM
500 pM
5 nM
20 nM
5 nM
5 nM
20 nM
5 nM
5 nM
20 nM
5 nM
5 nM
a The approximate ED50 values were estimated from the dose response curves in Figure 2 at the half-maximal stimulation of intracellular calcium which
is the level between two steady-state levels. DHT, Dihydrotestosterone; T, testosterone.
b Levels are the basal level and the intermediate calcium plateau, when androgen concentrations are between 10 and 100 pM.
c Levels are the intermediate calcium plateau at 10–100 pM androgens and the maximal calcium concentration at saturating androgen concentrations.
d Levels are (right curves in Fig. 2) the basal and maximal level.
nM testosterone, R1881, and DHT for LNCaP and PC3
cells, a persistent elevation of calcium after the transient
peak was observed. The response pattern of cells stimulated
with DHT was different from that of testosterone or R1881,
because concentrations of DHT below 1 nM did not affect
intracellular calcium. We constructed two dose-response
curves from the kinetic data of each cell type, one describ-
ing the transient peak levels at approximately 2 min after
hormone addition, and one describing the dose-dependent
plateau levels after approximately 10 min (Fig. 2). The
dose-response curves of the three cell types were very sim-
ilar and a biphasic stimulation pattern could be recognized.
Approximate ED50 values of the two phases of stimulation
in the three cell types are given in Table 1.
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FIG. 3. Inhibition of the calcium response. The left curves show the effect of a) 1000 nM cyproterone acetate, b) 1000 nM hydroxyflutamide, and c)
1000 nM finasteride (F) on the response of rat Sertoli cells to 10 nM testosterone (present during the time indicated by the black bar). The curves on
the right show the inhibiting effect of 1000 nM F during stimulation of Sertoli cells with d) 10 nM dihydrotestosterone and e) 10 nM R1881. Cells were
preincubated for 20 min with inhibitors, which also remained present in the superfusion medium during the stimulation phase. Data are representative
of at least six individual experiments.
Steroid Specificity
The specificity of the response system in the three cell
types was tested by challenging the cells with various com-
pounds at a concentration of 1000 nM and measuring the
intracellular calcium levels for a period of 15 min. The
androstane-derived compounds epitestosterone, 5b-dihy-
drotestosterone, androstenedione, 11b-hydroxyandrostene-
dione, dehydroepiandrosterone, 5a-androst-16en-3a-ol, 5b-
androstan-3b-ol-17–one, 5a-androstane-3,17-dione, 5a-an-
drost-3-one, 5a-androst-16-en-3-one, and 5a-androst-16-
en-3b-ol did not stimulate calcium signaling. Similarly,
progesterone and estradiol-17b; two antiandrogens, cyprot-
erone acetate (CPA) and HF; and the inhibitor of 5a-steroid
reductase, finasteride, had no effect on calcium levels.
Inhibition of Response
Inhibitory effects of various compounds were investi-
gated by preincubating the cells with 1000 nM HF or CPA
for 20 min prior to perfusion with 10 nM testosterone. The
same responses were observed in the three cell types: HF
completely blocked the androgen-induced calcium increas-
es, whereas CPA did not interfere with the calcium signal-
ing system. Finasteride, a specific inhibitor of 5a-steroid
reductase [45], inhibited the response induced by 10 nM
testosterone, R1881, and DHT when present at 1000 and
100 nM, but not at 10 nM (Fig. 3, Table 2).
Interactions of Androgens with the Cell Surface
To determine whether testosterone could induce a cal-
cium response directly at the cell surface, testosterone co-
valently bound to BSA (T:BSA), which cannot enter the
cells, was used. Figure 4, a and b, shows that the calcium
response to 10 nM testosterone in Sertoli cells is the same
for unbound testosterone and for testosterone covalently
bound to albumin. No calcium response was found to un-
conjugated albumin. When Sertoli cells and LNCaP cells
were perfused with T:BSA conjugated to FITC, an increase
in fluorescence intensity was seen when T:BSA-FITC was
in the perfusion chamber, but the fluorescence disappeared
completely after washing out of the conjugate (Fig. 4c).
BSA conjugated to FITC but without testosterone showed
the same result (Fig. 4d), indicating that the presence of
testosterone has no effect on the retention of the albumin
conjugate on the plasma membrane. It was not possible to
evaluate the biological activity of the FITC-labeled T:BSA
because the FITC fluorescence made it impossible to mea-
sure the fluorescence of the calcium dyes. Thus, transient
and reversible interactions between the androgen conjugate
and the plasma membrane appear sufficient for generating
at least the transient response.
We have also investigated interactions between uncon-
jugated steroids and the plasma membrane of intact LNCaP
cells by using tritiated R1881 and classical conditions for
binding studies in intact cells. Because CPA can bind to
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TABLE 2. Effect of inhibitors on intracellular calcium concentrations stimulated by 10 nM testosterone in rat Sertoli cells and human prostate cancer
cells.
Response
Sertoli cells
Basala
Ca21 (nM)
Peakb
Ca21 (nM)
LNCaP cells
Basal
Ca21 (nM)
Peak
Ca21 (nM)
PC3 cells
Basal
Ca21 (nM)
Peak
Ca21 (nM)
Control
Hydroxyflutamide (1000 nM)
Cyproterone acetate (1000 nM)
Finasteride (1000 nM)
138 6 17c
144 6 12
120 6 16
138 6 13
431 6 9c
138 6 7
430 6 12d
141 6 9
144 6 14
139 6 11
132 6 16
142 6 11
421 6 19d
137 6 7
416 6 11d
144 6 12
142 6 19
147 6 9
143 6 7
148 6 10
432 6 6d
144 6 11
428 6 14d
146 6 7
a Basal Ca21 levels were recorded before addition of testosterone.
b Peak Ca21 levels were recorded 2 min after testosterone addition.
c Data represent mean 6 SEM of four individual experiments performed in triplicate.
d P , 0.0005, when compared with controls.
the nuclear androgen receptor but does not interfere with
the calcium signaling pathway, it was used to suppress
binding of R1881 to the nuclear receptor without influenc-
ing the membrane system. In the presence of 1000 nM
CPA, specific binding of 3H R1881 after 1 h incubation
could not be demonstrated. This was because residual bind-
ing of 5 nM 3H R1881 after 1 h incubation and 15 rapid
washings with medium containing 1000 nM CPA could not
be discriminated from nonspecific 3H R1881 binding in the
presence of 1000 nM unlabeled R1881. However, specific
nuclear binding of R1881 was 10–20 times higher than
nonspecific binding after equilibration of the cells with 5
nM 3H R1881 for 1 h in the absence of CPA or unlabeled
R1881 at either 4 or 378C. With immunocytochemical tech-
niques the presence of the nuclear receptor could be shown
in the LNCaP cells and Sertoli cells, but not in the PC3
cells (data not shown).
Aspects of Calcium Signaling
To study whether the androgen-induced calcium increas-
es are due to an extracellular influx of calcium or to calcium
mobilization from intracellular stores, experiments were
carried out without calcium in the medium. When 5 mM
EGTA was added to the medium, the basal intracellular
calcium level was reduced and addition of androgens did
not induce an increase in calcium levels (Fig. 5b, Table 3).
Following preincubation with a voltage-gated calcium
channel blocker, verapamil (100 mM), for 20 min, only a
small increase in calcium levels was observed after andro-
gen addition (Fig. 5c, Table 3). These results show that
calcium channels in the plasma membrane play an impor-
tant role in calcium signaling.
Effects of Pulse Exposures to Testosterone
Because the binding studies showed that androgens in-
teract reversibly with the plasma membrane, we have used
the perfusion system to investigate the calcium response
after transient exposure (150 sec) to androgens. Under these
conditions, the persistent elevation of calcium after the tran-
sient peak was only 5.21% 6 1.33, for 10 nM testosterone,
and 5.65% 6 1.91, for 100 nM testosterone (n 5 6), lower
than during continuous exposure to testosterone. The sim-
ilarities in the response pattern between continuous and
pulse exposure is an indication that the response is mainly
determined by the initial changes in steroid concentrations.
We therefore tested the response after two or three brief 30-
sec pulses of 10 nM testosterone (Fig. 6, a and b), and
found that the effect of the second or third pulse was less
than the initial response. On one hand, the duration of the
response after a 30-sec pulse of 10 nM testosterone (Fig.
6d) is transient, and calcium levels return to basal levels
within approximately 30 min; on the other hand, a long-
term response lasting for at least 50 min was obtained after
a 30-sec stimulation with 100 nM testosterone (Fig. 6c).
Gap Junctional Communication
At least part of the calcium signaling pathways are cou-
pled to phosphorylation cascades. Because GJIC can be
modulated via phosphorylation, we have investigated
whether androgens can rapidly affect GJIC. GJIC was mea-
sured using scrape loading-dye transfer in Sertoli cells be-
cause it is known that Sertoli cells communicate with each
other via gap junctions [46]. Limited dye transfer was ob-
served between Sertoli cells in the control situation (dye
transfer 5.92% 6 0.36 of the area). The dye transfer was
markedly increased 15 min after addition of testosterone to
the cells (dye transfer 29.59% 6 1.06 of the area, n 5 4,
P , 0.0005), indicating an increase in GJIC (Fig. 7). A
similar response to testosterone (dye transfer 28.31% 6
0.62 of the area, n 5 4, P , 0.0005) was observed in the
presence of cycloheximide (100 mM), which completely in-
hibits protein synthesis. LNCaP cells and PC3 cells showed
no GJIC, indicating the specificity of the method.
DISCUSSION
The majority of androgen effects are mediated by the
nuclear androgen receptor that is already maximally stim-
ulated when free steroid concentrations in the target cells
are 1 nM or lower [6]. It is difficult to envisage how these
receptors can respond to higher androgen concentrations
when they are already saturated. As yet there is no evidence
that androgen receptors can produce specific signals de-
pending on the degree of oversaturation. Nevertheless, bi-
ological effects at such high concentrations of androgens
have been described [1–6, 44]. Thus, a low-affinity sensory
system must operate to signal the changes in androgen con-
centration at these relatively high concentrations [7]. Many
so-called nongenomic cell surface effects of steroids, re-
cently described in the literature [8–26], possess this prop-
erty and this alternative low-affinity sensory system could
operate in conjunction with the nuclear high-affinity recep-
tor [1, 3–5]. The results of the present investigation confirm
that alternative androgen actions can take place at the plas-
ma membrane level and that there is not only a response
to high androgen levels up to 100 nM, but also to androgen
concentrations of 1 pM. Moreover, they show a steroid
specificity that has certain similarities with the nuclear re-
ceptor, but which also shows clear differences, especially
with respect to effects of antiandrogens and finasteride.
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FIG. 4. Interactions between androgens and cell surface. The left curves show intracellular calcium levels in LNCaP cells before and during superfusion
(indicated by the black bar) with a) 10 nM testosterone and b) 10 nM testosterone covalently bound to BSA. The right curves show the fluorescence
intensity of LNCaP cells before, during, and after superfusion for 150 sec (black bar) with c) testosterone covalently bound to BSA-FITC and d) the BSA-
FITC without testosterone. Similar results were obtained in two other experiments with LNCaP cells and three with Sertoli cells.
Steroid Specificity
The biologically active ligands, testosterone, DHT, and
R1881, which can act via the nuclear receptor, were also
active in rapid calcium signaling. Other steroids such as
estradiol-17b, progesterone, 17a-testosterone, 5b-dihydro-
testosterone, androstenedione, 11b-hydroxyandrostenedi-
one, 5a-androst-16en-3a-ol, dehydroepiandrosterone, 5a-
androstane-3,17-dione, 5a-androst-3-one, 5a-androst-16-
en-3-one, 5a-androst-16-en-3b-ol, HF, CPA, and finasteride
were not active even when tested at concentrations of 1000
nM. The testosterone-, R1881-, and DHT-induced calcium
responses could be inhibited by the androgen antagonist
HF; however, in contrast to effects on the nuclear receptor,
the testosterone-, R1881-, and DHT-activated calcium tran-
sients were not inhibited by CPA but could be inhibited by
finasteride, which is a specific inhibitor of 5a-steroid re-
ductase [45].
The inhibition of the testosterone-induced effects by fi-
nasteride could, in theory, be explained by an inhibition of
a very active 5a-reductase. However, R1881 is a metabol-
ically stable androgen, testosterone is covalently bound to
albumin, and DHT cannot be activated by intracellular 5a-
reductase. Thus, it appears unlikely that the action of fi-
nasteride is due to inhibition of 5a-reductase activity. A
more likely explanation is that finasteride interacts with the
androgen binding site of the receptor at the cell membrane.
The results with LNCaP cells also show that the binding
site of the membrane system differs from the receptor in
the nucleus because CPA, HF, progesterone, and estradiol,
which can stimulate cell growth due to a mutation in the
classical androgen receptor in this cell line [6], do not ac-
tivate the receptor in the membrane.
Rapid effects of various androgens on LNCaP cells have
been reported previously by Steinsapir et al. [20]. Effects
of testosterone and DHT on calcium signaling in freshly
isolated Sertoli cells have been reported by Gorczynska and
Handelsman [26], but the lowest dose to show a response
was 300 nM. Enzymatic and mechanical damage during the
isolation procedure of the cells may have caused this low
sensitivity because it has been shown that trypsin treatment
reduces the membrane binding of monoclonal antibodies
and cellular responses to glucocorticoids in lymphoma cells
[27]. Gorczynska and Handelsman described that HF and
finasteride blocked the effect of testosterone, whereas fi-
nasteride could not affect the response to DHT, leading to
the conclusion that 5a-reduction of testosterone is neces-
sary for the effect. Our data do not support this interpre-
tation. Audy et al. [47] reported calcium fluxes in LNCaP
cells induced by estradiol (100 pM–100 nM) and 10 nM
DHT within 6 min. Flutamide completely inhibited the an-
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FIG. 5. Regulation of calcium response. Intracellular calcium response
in rat Sertoli cells: effect of a) 10 nM testosterone, inhibition of response
after preincubation for 20 min, and superfusion with b) 5 mM EGTA and
c) 100 mM verapamil.
TABLE 3. Effects of EGTA and Verapamil on intracellular calcium concentrations stimulated by 10 nM testosterone in rat Sertoli cells and human prostate
cancer cells.
Response
Sertoli cells
Basala
Ca21 (nM)
Peakb
Ca21 (nM)
LNCaP cells
Basal
Ca21 (nM)
Peak
Ca21 (nM)
PC3 cells
Basal
Ca21 (nM)
Peak
Ca21 (nM)
Control
EGTA (5 mM)
Verapamil (100 mM)
138 6 17c
65 6 16
144 6 11
431 6 9d
43 6 12
259 6 15e
144 6 14
51 6 14
141 6 12
421 6 19d
32 6 16
252 6 6e
142 6 19
68 6 8
145 6 9
432 6 6d
59 6 6
234 6 13e
a Basal Ca21 levels were recorded before addition of testosterone.
b Peak Ca21 levels were recorded 2 min after testosterone addition.
c Data represent mean 6 SEM of four individual experiments performed in triplicate.
d P , 0.0005, when compared with controls.
e P , 0.001 when compared with controls.
drogen response but had no effect on the estradiol response.
Their data suggest that separate binding sites on the plasma
membrane mediate the responses for the different sex ste-
roids. Our responses showed completely different kinetics
and steroid specificity without an effect of estradiol. Dif-
ferent LNCaP sublines could explain these discrepancies.
More than One Receptor
It is difficult to envisage how one binding site can sense
and transmit information from a range of androgen concen-
trations that spans 5 orders of magnitude. A receptor clus-
tering model has recently been proposed for chemotactic
receptors on Escherichia coli bacteria to explain that one
receptor for aspartate can sense gradients of attractants over
5 orders of magnitude [48]; however, there is no evidence
that such a system operates in cells other than bacteria. Our
calcium response data are compatible with a two-membrane
receptor model in spermatozoa for progesterone, as shown
by Luconi et al. [49]. Similar to their observations in sper-
matozoa with progesterone, we observed in three different
cell types comparable biphasic dose-response curves gen-
erated by testosterone or R1881, but our responses occurred
at approximately 1000-fold lower concentrations (pM and
nM, respectively) when compared to progesterone. Similar
to the restricted action of derivatives from progesterone on
spermatozoa, DHT could activate only the low-affinity site
of the responsive membrane system in our cells. It is un-
likely that metabolism of DHT caused the absence of low-
dose effects because under the perfusion conditions, the
extracellular concentration of DHT is kept constant. More-
over, if metabolism had occurred, the entire dose-response
curve would have been shifted to the right.
At the present time there is no structural information of
the receptor for androgens in the membrane. Results from
recent experiments show that classical nuclear receptors
(perhaps modified), especially estrogen receptors, can also
activate the mitogen-activated protein kinase pathway [28].
It has also been shown that a small fraction (4%) of the
nuclear receptor can associate with the plasma membrane
and that these membrane-associated receptors also bind the
same ligands as the nuclear receptor with a similar high
affinity. They can also activate signal transduction path-
ways via G proteins, although with a different steroid spec-
ificity, when compared with the nuclear receptor [29]. For
the androgen receptor, there is also evidence for alternative
processing. Immunoreactivity of androgen-receptor proteins
have been shown in T cells but no androgen binding activ-
ity could be shown [23, 24]; however, there was no evi-
dence that such alternatively processed products were pre-
sent in the plasma membrane of T cells. The membrane
receptor in our cells could, in theory, also originate from
alternative processing of the nuclear receptor, but the many
similarities in the response characteristics independent of
the nuclear receptor status; no receptors in PC3 cells, mu-
tated receptors with very different steroid specificity in
LNCaP cells, and normal receptors in Sertoli cells, make
this possibility very unlikely. Moreover, the interactions be-
tween androgens and receptors on the plasma membrane
and in the nucleus are so different that, with classical bind-
ing techniques (including several washing steps), we could
not detect any specific retention of R1881 to the plasma
membrane of LNCaP cells, whereas nuclear binding was
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FIG. 6. Effects of pulse exposures to androgens. Intracellular calcium levels in rat Sertoli cells were recorded before, during, and after a) two and b)
three consecutive 30-sec pulses of 10 nM testosterone (arrows). The right curves (c and d) show the effect of a single 30-sec pulse of c) 100 nM
testosterone and d) 10 nM testosterone (arrow) over a 60-min instead of a 16-min period. Similar observations were made in four other experiments.
normal. A high dissociation rate constant for these mem-
brane interactions could explain the poor retention of
R1881.
As a result of these findings, we propose that proteins
not coded by the mRNA for the nuclear receptor most prob-
ably mediate the calcium signaling.
Characteristics of Calcium Signaling
High calcium levels persisted after brief exposure (150
or 30 sec) to high concentrations of androgens when cells
were perfused with medium without androgens for periods
up to 45 min. Because androgens do not bind tightly to the
membrane, this retention of the calcium response occurs
without the presence of steroids on the membrane receptors.
Thus, a brief exposure to androgens can induce a long-term
response. All we can conclude from experiments with cal-
cium channel blockers and zero calcium in the incubation
medium is that external calcium is required for the calcium
signaling, but we do not know how this activated state is
initiated by the presence and maintained in the absence of
androgens.
Lieberherr and Grosse [22] described dose-dependent ef-
fects of androgens in osteoblasts also greater than 5 orders
of magnitude of androgen concentrations, but their dose
response curve was bell-shaped. Their responses were also
different from ours in other respects: osteoblasts responded
within 5 and not 30 sec after administration of the andro-
gen; testosterone and DHT gave similar responses; and the
transient calcium response was not inhibited by the absence
of extracellular calcium, whereas it was inhibited by inhib-
itors of phospholipase C. Together with our data, there are
thus many different possibilities for activation of calcium
transients by cell surface actions of androgens.
Effects on Gap Junctions
We have investigated changes in GJIC between Sertoli
cells as a possible downstream event of the calcium sig-
naling pathway because it is known that variations in sec-
ond messengers such as Ca21, H1, and cAMP can regulate
the efficiency of the gap junctions via phosphorylation of
the connexin proteins [50]. Androgens increased gap junc-
tional efficiency between Sertoli cells within 15 min in the
absence of protein synthesis. We have interpreted this gap
junctional regulation as a nongenomic, functional response
of the Sertoli cell to testosterone, which could be mediated
via a calcium signal. Pluciennik et al. [51] have shown an
increase in GJIC following incubation of rat Sertoli cells
with FSH. The same authors also reported an interruption
of the junctions after 15 min of exposure to 1–25 mM tes-
tosterone propionate or estradiol-17b propionate [52, 53].
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FIG. 7. Gap junctional intercellular communication (GJIC). Fluores-
cence dye transfer through gap junctions in (upper panel) control and
(lower panel) testosterone-treated rat Sertoli cells. Cells were incubated
with 10 nM testosterone for 15 min and subsequently scrape-loaded with
lucifer yellow dye. Dye transfer is a measure of GJIC. Micrographs are
representative of six individual experiments. Bar 5 20 mm.
These effects were observed only with high concentrations
of steroid esters in the absence of changes in intracellular
calcium concentrations, suggesting direct effects of the ste-
roid esters on membrane properties. Thus, there appear to
be different modes for regulation of GJIC between Sertoli
cells, with androgen-induced calcium signaling pathways as
one of the possibilities.
Biological Relevance of Androgen-Induced Calcium
Signaling
An important question is whether these androgen-acti-
vated signaling pathways can activate specific cellular func-
tions or whether they merge with pathways already under
the control of protein hormones or growth factors. As stated
in the Introduction, Sertoli cells require high local androgen
levels for proper functioning. It is possible that the persis-
tent high calcium levels, which are generated only by high
levels of androgens and not by EGF or FSH, are a reflection
of such a specific pathway. Such a specific calcium pathway
could explain why significant stimulation of ABP secretion
by a combination of Sertoli and peritubular myoid cells
occurs only when testosterone concentrations are higher
than 4 nM [5] and not between 0.1–1 nM, which is the
normal sensitivity for androgen-responsive cells [6].
In LNCaP cells, low levels of androgens stimulate cell
growth, whereas concentrations higher than 1 nM (above
the affinity constant of the receptor), inhibit cell growth,
further stimulate the secretion of prostate specific antigen,
and increase the percentage of androgen-receptor-positive
cells [54]. Other investigators [6, 44, 55] using LNCaP cells
have also observed growth-inhibitory effects of R1881 and
DHT when present at concentrations higher than 1 nM,
whereas HF, CPA, progesterone, and estradiol-17b all stim-
ulate cell growth even at 100 nM. The androgen receptor
is essential for this growth inhibition because androgen-
dependent growth inhibition also occurs in MCF-7 cells
after transfection with androgen receptors, and is maximal
at concentrations of R1881 below 1 nM [56]. It is puzzling
that inhibition of cell growth in LNCaP cells requires high-
er concentrations than 1 nM R1881, testosterone, or DHT
and that other ligands that stimulate the mutated androgen
receptor do not induce growth inhibition. Because we have
shown that only R1881, testosterone, and DHT stimulate
intracellular calcium in LNCaP cells, we hypothesize that
high intracellular calcium somehow plays a role in the an-
drogen receptor-mediated growth inhibition. The growth re-
sponse of muscles to pharmacological doses of androgens
(drug abuse), is also difficult to explain with the properties
of the high-affinity nuclear receptor alone [57, 58]. This
hypertrophy of muscle cells may thus also require a com-
plementary low-affinity response system in addition to the
high-affinity androgen receptors in the nucleus.
It is known that membrane receptors for proteins can
modulate different nuclear steroid receptors, they can even
activate the steroid receptors without the presence of ligand
[59]. The importance of such external regulatory networks
for the outcome of steroid hormone action in the nucleus
was recently stressed by O’Malley et al. [60], when they
proposed that membrane transduction pathways, activated
by growth factors, which interact with the nuclear receptor
via intracellular phosphorylation cascades, may ‘‘set the nu-
clear receptor thermostat’’ for responses to steroids. In a
similar fashion, the androgen-induced calcium signaling
pathway can also influence the functional properties of the
nuclear androgen receptor. To investigate this possibility for
fine-tuning of the androgen receptor, selective agonists and
more knowledge on the structure and function of the pu-
tative membrane receptor or receptors is necessary.
NOTE ADDED IN PROOF
Important new information on variability of hormone in-
duced calcium signaling can be found in a multi-author
commentary: ‘‘Calcium confusion: is the variability in cal-
cium response by Sertoli cells to specific hormones mean-
ingful or simply redundant?’’ by FFG Rommerts, FM Lyng,
E von Ledebur, L Quinlan, GR Jones, JB Warchol, M Ste-
fanini, N Ravindranath, M Joffre. J Endocrinol; 2000.
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